Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ejhaem|February 26, 2024
Post-lumbar puncture cerebral vein thrombosisVincenzo Marasco, Francesca Gianniello, Aldo Paolucci, et al.
Cancer Reports (Hoboken, N.J.)|April 15, 2025
Tailored Therapeutic Approach in a Patient With Diffuse Large B-Cell Lymphoma With Meningeal Infiltration, Concurrent Classic Hodgkin Lymphoma, and Smoldering Multiple Myeloma: A Case ReportGiusy Ceparano, Daniele Lorenzini, Maurilio Ponzoni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2018
Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell TransplantationAlessandra Forcina, Francesca Lorentino, Vincenzo Marasco, et al.
Cancer|November 17, 2022
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacyAnna Guidetti, Anna Dodero, Alice Lorenzoni, et al.
Blood Advances|July 14, 2023
Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trialFederico Stella, Vincenzo Marasco, Giorgia Virginia Levati, et al.
British Journal of Haematology|October 14, 2021
T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignanciesVincenzo Marasco, Cristiana Carniti, Anna Guidetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell TransplantationAlessandra Forcina, Paola M V Rancoita, Magda Marcatti, et al.
British Journal of Haematology|July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 studyVincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
Leukemia & Lymphoma|January 2, 2024
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategiesSimonetta Viviani, Anna Vanazzi, Samuele Frassoni, et al.
The Lancet. Haematology|August 6, 2025
Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trialSara Bringhen, Lorenzo Cani, Elisabetta Antonioli, et al.
Pageof 2